Literature DB >> 3621113

The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer.

C Kamby, B Guldhammer, I Vejborg, N Rossing, H Dirksen, S Daugaard, H T Mouridsen.   

Abstract

The occurrence of bone marrow carcinosis was investigated in 380 patients at the time of first recurrence of breast cancer. Results were related to results from radiographic bone survey, 99mTc MDP bone scintigraphy, clinical examination and serum alkaline phosphatase and serum calcium levels. Eighty-seven patients (23%) had tumor cells in the bone marrow. X-rays showed metastases in 78% of the patients with and in 16% of the patients without bone marrow carcinosis. The diagnostic efficiency of x-rays with bone marrow biopsy as the key diagnostic factor was 83%, and it was superior to that of other investigation methods. Bone tissue biopsies were positive alone in 15 patients (17%) and marrow aspirations were positive alone in seven patients (8%). Imprint preparations were positive alone in 7% of the patients and bone tissue biopsy in 5% of the patients. Heavy tumor infiltration (greater than or equal to 50%) of the bone marrow was associated with the occurrence of numerous regions of radiographically involved bone lesions and with histopathologic evidence of bone destruction. Furthermore, pronounced bone formation and marrow fibrosis were more commonly seen in patients with osteosclerotic bone metastases than in patients with osteolytic bone metastases. This study provides evidence that the primary soil of metastatic bone disease in human breast cancer is the bone marrow and that radiographic evidence of bone metastases is a result of an invasion and destruction of the bone tissue matrix by tumor cells from the marrow cavity.

Entities:  

Mesh:

Year:  1987        PMID: 3621113     DOI: 10.1002/1097-0142(19870915)60:6<1306::aid-cncr2820600624>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.

Authors:  Yoshiaki Shinden; Keishi Sugimachi; Fumiaki Tanaka; Kenji Fujiyoshi; Yuko Kijima; Shoji Natsugoe; Koshi Mimori
Journal:  Mol Clin Oncol       Date:  2017-11-15

2.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.

Authors:  Dalit Barkan; Lara H El Touny; Aleksandra M Michalowski; Jane Ann Smith; Isabel Chu; Anne Sally Davis; Joshua D Webster; Shelley Hoover; R Mark Simpson; Jack Gauldie; Jeffrey E Green
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 3.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

Review 4.  Micrometastatic bone marrow involvement: detection and prognostic significance.

Authors:  S Braun; K Pantel
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

5.  Prognostic factors for bone metastases in breast cancer.

Authors:  M A Ulloa; E C Merchan
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

6.  Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.

Authors:  M C Mathieu; S Friedman; J Bosq; B Caillou; M Spielmann; J P Travagli; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

Review 7.  Radiological detection of bone and bone marrow metastases.

Authors:  H Jacobsson; H Göransson
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

8.  [Analysis of therapy-relevant receptors in bone marrow carcinosis : Comparison of pathological and clinical parameters].

Authors:  G Massenkeil; C Gropp; H Kreipe; K Hussein
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

9.  Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Authors:  Sandip Basu; Drew Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 10.057

10.  Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.

Authors:  C Kamby; B B Rasmussen; B Kristensen
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.